Cargando…
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
The coronavirus disease 2019 (COVID-19) pandemic has placed a significant burden on hospitals worldwide. Objective biomarkers for early risk stratification and clinical management are still lacking. The aim of this work was to determine whether bioactive adrenomedullin can assist in the risk stratif...
Autores principales: | Simon, Tim-Philipp, Stoppe, Christian, Breuer, Thomas, Stiehler, Lara, Dreher, Michael, Kersten, Alexander, Kluge, Stefan, Karakas, Mahir, Zechendorf, Elisabeth, Marx, Gernot, Martin, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069401/ https://www.ncbi.nlm.nih.gov/pubmed/33924637 http://dx.doi.org/10.3390/jcm10081667 |
Ejemplares similares
-
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study
por: Bleilevens, Christian, et al.
Publicado: (2021) -
The Potential Impact of Heparanase Activity and Endothelial Damage in COVID-19 Disease
por: Zechendorf, Elisabeth, et al.
Publicado: (2022) -
Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery
por: Hill, Aileen, et al.
Publicado: (2023) -
Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101)
por: Karakas, Mahir, et al.
Publicado: (2020) -
A Potential Association between Ribonuclease 1 Dynamics in the Blood and the Outcome in COVID-19 Patients
por: Zechendorf, Elisabeth, et al.
Publicado: (2023)